Rx Medicare

The pharmaceutical company Roche on Wednesday announced a program to help ensure developing countries have access to its antiviral Tamiflu, for “the management of a novel influenza strain defined by the WHO as having significant and current pandemic potential,” Reuters reports (Egenter, 7/1).

Read More…

Related Posts

• Publix To Offer Flu Vaccination Program
• FDA Warns About Fraudulent Tamiflu
• Molecular Explanation For The Evolution Of Tamiflu Resistance
• The Immune System May Offer Method For Stopping Infection-Caused Inflammation By Targeting Blood Vessels
• Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
• Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu
• Update On Person To Person Spread Of Swine Flu Resistant To Tamiflu, Wales
• In Their Own Words: Kids Offer Advice On H1N1 Flu
• Could Vaccination For Children Against Seasonal Flu Stop Immunity Developing Against Pandemic Strains?
• CT Scans Show Patients With Severe Cases Of H1N1 Are At Risk For Developing Acute Pulmonary Emboli
• Publix Pharmacies To Compound Tamiflu Into Oral Suspension
• Tamiflu Metabolite Measured In Japanese Sewage Discharge, River Water
• Walgreens To Compound Tamiflu Oral Suspension For Children In Response To Supply Shortage
• Walgreens To Offer Seasonal Flu Shots At More Than 7,000 Points Of Care Nationwide Beginning September 1st
• MDA, Walgreens Join Forces To Offer Seasonal Flu Shots

Tags: countries, developing, discounted, efficacy, offer, roche, tamiflu

This entry was posted on Friday, July 3rd, 2009 at 8:07 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.